152 related articles for article (PubMed ID: 23013405)
41. Cutaneous intravascular anaplastic large cell lymphoma.
Wang L; Li C; Gao T
J Cutan Pathol; 2011 Feb; 38(2):221-6. PubMed ID: 20337769
[TBL] [Abstract][Full Text] [Related]
42. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
43. Anaplastic large cell lymphoma: another entity in the differential diagnosis of small round blue cell tumors.
Gustafson S; Medeiros LJ; Kalhor N; Bueso-Ramos CE
Ann Diagn Pathol; 2009 Dec; 13(6):413-27. PubMed ID: 19917480
[TBL] [Abstract][Full Text] [Related]
44. Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma.
Gadage VS; Subramanian PG; Galani KS; Sehgal KK; Johari SP; Ghogale VS; Badrinath Y; Ashok K; Gujral S
Indian J Pathol Microbiol; 2011; 54(3):599-602. PubMed ID: 21934233
[TBL] [Abstract][Full Text] [Related]
45. ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation.
Ando K; Tamada Y; Shimizu K; Akita Y; Watanabe D; Nakamura S; Hara K; Matsumoto Y
Acta Derm Venereol; 2010 Mar; 90(2):198-200. PubMed ID: 20169312
[No Abstract] [Full Text] [Related]
46. ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemia.
Liu T; He M; Carlson DL; Hedvat C; Teruya-Feldstein J
Int J Surg Pathol; 2010 Oct; 18(5):424-8. PubMed ID: 18794171
[TBL] [Abstract][Full Text] [Related]
47. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
48. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as retroperitoneal fibrosis.
Hammer ST; Jentzen JM; Lim MS
Hum Pathol; 2011 Nov; 42(11):1810-2. PubMed ID: 21658744
[TBL] [Abstract][Full Text] [Related]
49. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
50. [Ki-1-positive anaplastic large-cell lymphoma with mediastinal involvement].
Makiguchi N; Ohsaki Y; Fujiuchi S; Yamamoto Y; Takahashi T; Ide H; Akiba Y; Nakano H; Miyokawa N; Kikuchi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):660-4. PubMed ID: 9294301
[TBL] [Abstract][Full Text] [Related]
51. [A case of idiopathic hypereosinophilic syndrome with hepatic involvement in a 5-year-old boy].
Kim YM; Lee YJ; Park JH; Lee JW; Lee CH
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):321-6. PubMed ID: 12499791
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, and biological activity of urea derivatives as anaplastic lymphoma kinase inhibitors.
af Gennäs GB; Mologni L; Ahmed S; Rajaratnam M; Marin O; Lindholm N; Viltadi M; Gambacorti-Passerini C; Scapozza L; Yli-Kauhaluoma J
ChemMedChem; 2011 Sep; 6(9):1680-92. PubMed ID: 21721129
[TBL] [Abstract][Full Text] [Related]
53. Composite ALK-negative anaplastic large cell lymphoma and small lymphocytic lymphoma involving the right inguinal lymph node.
Persad P; Pang CS
Pathol Res Pract; 2014 Feb; 210(2):127-9. PubMed ID: 24169448
[TBL] [Abstract][Full Text] [Related]
54. Acute Lymphoblastic Leukemia with Hypereosinophilia in a Child: Case Report and Literature Review.
Ferruzzi V; Santi E; Gurdo G; Arcioni F; Caniglia M; Esposito S
Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29867057
[No Abstract] [Full Text] [Related]
55. Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.
d'Elbée JM; Parrens M; Mercié P; Longy Boursier M; Dieval C; de Mascarel A; Duffau P; Dubus P; Fricain JC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e185-90. PubMed ID: 23669204
[TBL] [Abstract][Full Text] [Related]
56. Skin involvement in ALK-negative systemic anaplastic large-cell lymphoma.
Hoshina D; Arita K; Mizuno O; Fujimoto K; Nishio M; Kondo T; Abe R; Shimizu H
J Am Acad Dermatol; 2012 Oct; 67(4):e159-60. PubMed ID: 22980280
[No Abstract] [Full Text] [Related]
57. Lymphoma-associated versus lymphocytic-variant hypereosinophilia.
D'Souza A; Pardanani A; Tefferi A
Leuk Lymphoma; 2012 Nov; 53(11):2103-4. PubMed ID: 22762549
[No Abstract] [Full Text] [Related]
58. An 8-year-old boy with hypereosinophilic syndrome.
Hosoki K; Nagao M; Iguchi K; Ihara T; Yamada Y; Higashigawa M; Kephart GM; Kita H; Fujisawa T
Int Arch Allergy Immunol; 2011; 155 Suppl 1():117-22. PubMed ID: 21646806
[TBL] [Abstract][Full Text] [Related]
59. The idiopathic hypereosinophilic syndrome.
Lin DA; Boyce JA
Allergy Asthma Proc; 2003; 24(6):417-20. PubMed ID: 14763243
[TBL] [Abstract][Full Text] [Related]
60. What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2022 Apr; 237():108982. PubMed ID: 35307610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
